A61M 2202/0474
Haemodiluting
Official title: haemodiluting
A61M2202/0474 (Haemodiluting) appears on 4 US grants and 5 published applications in this corpus.
Search patents in A61M- Granted patents
- 4
- Published applications
- 5
- Assignees
- 2
- Inventors
- 7
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 3 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- System and methods incorporating replacement fluid maximization11 Aug 2026US 12,702,738 B2Fenwal, Inc.
- System and methods incorporating replacement fluid maximization20 Jun 2023US 11,679,188 B2Fenwal, Inc.
- Devices and methods for imaging and treating blood vessels14 Sep 2021US 11,116,948 B2A V Medical Technologies, Ltd.
- Medical solution authentication8 Jan 2019US 10,172,996 B2
- System and Methods Incorporating Replacement Fluid Maximization31 Aug 2023US 2023/0270926 A1Fenwal, Inc.
- System and Methods Incorporating Replacement Fluid Maximization29 Oct 2020US 2020/0338252 A1Fenwal, Inc.
- Devices and methods for imaging and treating blood vessels17 Nov 2016US 2016/0331944 A1A V Medical Technologies, Ltd.
- Methods and systems for collecting mononuclear cells28 Apr 2016US 2016/0114095 A1Fenwal, Inc.
- Medical solution authentication25 Feb 2016US 2016/0051746 A1Fenwal, Inc.
Most cited
By later US patents